Cargando…

Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients

BACKGROUND: Hepatocyte growth factor (HGF), c-Met, and basic fibroblast growth factor (bFGF) are molecular markers that contribute to angiogenesis and proliferation in numerous cancers. We assessed the prognostic significance of these factors in tumour and stroma of endometrial cancer (EC) patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Felix, A S, Edwards, R P, Stone, R A, Chivukula, M, Parwani, A V, Bowser, R, Linkov, F, Weissfeld, J L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388566/ https://www.ncbi.nlm.nih.gov/pubmed/22617129 http://dx.doi.org/10.1038/bjc.2012.200

Ejemplares similares

Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer
por: Gowardhan, B, et al.
Publicado: (2005)

Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1–PI3K–Rac1 pathway
por: Kamura, S, et al.
Publicado: (2010)

Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells
por: Hirotsu, M, et al.
Publicado: (2009)

Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer
por: Takahashi, N, et al.
Publicado: (2014)

High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer
por: Zagouri, F, et al.
Publicado: (2013)

Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone
por: Aldridge, S E, et al.
Publicado: (2005)

Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer
por: Yagi, H, et al.
Publicado: (2005)

Insulin-like growth factor-I receptor activity is essential for Kaposi's sarcoma growth and survival
por: Catrina, S-B, et al.
Publicado: (2005)

Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma
por: Tuynman, J B, et al.
Publicado: (2008)

Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients
por: Scartozzi, M, et al.
Publicado: (2011)

Purinergic regulation of vascular endothelial growth factor signaling in angiogenesis
por: Rumjahn, S M, et al.
Publicado: (2009)

Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease
por: Darby, S, et al.
Publicado: (2009)

Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
por: Wallin, U, et al.
Publicado: (2011)

Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis
por: Mohammed, R A A, et al.
Publicado: (2007)

Identification of novel growth factor-responsive genes in neuroendocrine gastrointestinal tumour cells
por: Hofsli, E, et al.
Publicado: (2005)

Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas
por: Bignotti, E, et al.
Publicado: (2008)

Molecular determination of epidermal growth factor receptor in normal and neoplastic colorectal mucosa
por: Piazzi, G, et al.
Publicado: (2006)

Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer
por: Ryan, A J, et al.
Publicado: (2009)

Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer
por: Huang, Y-F, et al.
Publicado: (2008)

Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA)
por: Kokubo, Y, et al.
Publicado: (2005)

MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines
por: Arriola, E, et al.
Publicado: (2011)

MicroRNA-126 and epidermal growth factor-like domain 7–an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial
por: Hansen, T F, et al.
Publicado: (2013)

Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas
por: Martinho, O, et al.
Publicado: (2009)

The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma
por: Åström, Pirjo, et al.
Publicado: (2017)

Significance of nerve growth factor overexpression and its autocrine loop in oesophageal squamous cell carcinoma
por: Tsunoda, S, et al.
Publicado: (2006)

Epidermal growth factor receptor (EGFR) downstream signalling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options
por: Scartozzi, M, et al.
Publicado: (2007)

Tumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer
por: Rao, S R, et al.
Publicado: (2017)

Regulation of anoikis resistance by NADPH oxidase 4 and epidermal growth factor receptor
por: Kim, Hyeryeong, et al.
Publicado: (2017)

Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression
por: Ko, Young San, et al.
Publicado: (2015)

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases
por: Goos, J A C M, et al.
Publicado: (2014)

The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-β2
por: Arslan, F, et al.
Publicado: (2007)

BRAF(V600E) melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity
por: Whipple, C A, et al.
Publicado: (2014)

Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma
por: Sonobe, M, et al.
Publicado: (2005)

Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin
por: Yates, C C, et al.
Publicado: (2007)

Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers
por: Savic, S, et al.
Publicado: (2008)

Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
por: Miyamoto, M, et al.
Publicado: (2011)

Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy
por: Nieto, Y, et al.
Publicado: (2007)

A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis
por: Nam, S Y, et al.
Publicado: (2011)

Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts
por: Wolpin, B M, et al.
Publicado: (2007)

Variability in functional p53 reactivation by PRIMA-1(Met)/APR-246 in Ewing sarcoma
por: Aryee, D N T, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kfq55hbodetkqo8plphru3uhll